Apraxin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Apraxin

Property Description
Active ingredient Naproxen Sodium
Pharmacological class Nonsteroidal Anti-Inflammatory Drug (NSAID)
Origin Synthetic, Propionic acid derivative
Forms Tablet, Oral suspension
General Purpose Analgesic, Anti-inflammatory, Antipyretic

Apraxin: Definition and Pharmacological Classification

Apraxin is a medicinal entity whose therapeutic action is derived entirely from its active pharmaceutical ingredient, Naproxen Sodium. It is clinically recognized and classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID), placing it in the major category of systemic agents used to modify pathways related to pain and inflammation.

This drug is specifically a synthetic propionic acid derivative, meaning its core chemical structure is manufactured, not sourced naturally. Apraxin is designated as a single-ingredient product and is intended for the oral route of administration, commonly supplied as a tablet or an oral suspension.

Active Ingredient, Forms, and General Therapeutic Purpose

The effectiveness of Apraxin hinges on the Naproxen Sodium component, which is a salt formulation utilizing a Sodium cation to enhance the speed at which the Naproxen molecule is absorbed into the bloodstream. This property of quicker dissolution is a differentiating factor, aiming for a rapid onset of effects compared to the base acid.

The general purpose of Apraxin is to provide a combined therapeutic effect across the body: it is inherently analgesic (pain-relieving), anti-inflammatory (swelling-reducing), and antipyretic (fever-reducing). Naproxen Sodium formulations are used for systemic symptom management to address the combined symptoms of pain, swelling, and fever.

Regulatory References

  1. Naproxen Classification and Use (NIH/NCBI StatPearls)

What side effects are possible with Apraxin?

Apraxin (Naproxen Sodium) is classified as a Nonsteroidal Anti-Inflammatory Drug (NSAID) whose safety profile is strictly defined by government regulatory documents, focusing on risks to specific physiological systems and serious adverse reactions.


Serious Adverse Reactions and Safety Constraints

The most significant risks documented by regulatory agencies involve the Cardiovascular System and the Gastrointestinal Tract. NSAIDs can increase the risk of serious cardiovascular thrombotic events, including myocardial infarction (heart attack) and stroke, which may be fatal. This risk may occur early in treatment and can increase with the duration of use. Similarly, the risk of serious gastrointestinal events, such as bleeding, ulceration, and perforation of the stomach or intestines, can occur without warning symptoms and may also be fatal. Severe, sometimes fatal, anaphylactic reactions and serious skin reactions (e.g., Stevens-Johnson syndrome, Toxic Epidermal Necrolysis) have also been reported.


Frequency and Organ Systems Affected

Adverse reactions are formally classified by frequency and grouped into System-Organ Classes. Common adverse reactions typically reported in regulatory summaries include: dyspepsia (indigestion), abdominal pain, nausea, headache, dizziness, and edema (fluid retention). Other systems that may be affected include the Renal (impaired function), Hepatobiliary (hepatotoxicity), and Nervous (tinnitus, drowsiness) systems.


Population-Specific Safety Notes

Regulatory documents highlight specific considerations for certain populations. Older adults face an increased risk for serious gastrointestinal adverse events, particularly bleeding and perforation. Use is constrained or avoided in patients with advanced renal disease and is discouraged starting at 30 weeks gestation due to risks to the fetus.

Overdose and Emergency Response

Overdose and When to Seek Help

If you believe a drug overdose has occurred, it is a medical emergency. You must seek immediate medical attention by contacting emergency services without delay.


Documented Overdose Profile

Overdose with Apraxin (which contains the active ingredient Dipyrone) has been associated with specific physiological responses, primarily affecting the renal system. The official documented presentation of an overdose may include transitory disturbances and inflammation of the renal tissue.

Overdose is considered one of the specific circumstances under which these renal-related concerns—which affect the body's ability to filter waste—can arise. This risk may be particularly relevant in individuals with a pre-existing history of renal disease.

Overdose Manifestations

System Affected Manifestation (As per Labeling)
Renal System Transitory disturbances and inflammation of the renal tissue.

What to Do in Case of Overdose

In the event of a suspected overdose, do not wait for symptoms to worsen. The most important action is to call emergency medical services immediately. Medical professionals will provide appropriate supportive care, which may include measures such as gastrointestinal decontamination if the ingestion was recent, and monitoring of vital signs. Recovery is generally likely with prompt, supportive medical treatment, though the severity of effects depends on the dose and individual factors. Do not attempt to self-treat the overdose or delay seeking professional help.

Therapeutic Uses of Apraxin

What Apraxin Treats: Main Uses and Benefits

Apraxin's primary role is to provide symptomatic relief and supportive therapeutic benefit across key domains where discomfort and inflammation pose a challenge to functional stability. This medicine is commonly used across domains where short-term symptom management is appropriate, addressing both pain and inflammation.

It is relevant in clinical settings that involve acute or unstable symptom patterns, such as those associated with headaches, muscle aches, menstrual discomfort, sprains, strains, or minor joint discomfort. This supportive assistance may help address symptom clusters that may become intense or disruptive.

Apraxin is commonly used to help with symptoms related to systemic imbalance, such as fever, providing valuable assistance in symptom management.

Quick Fact: Relief for Pain & Inflammation

Apraxin is often used during phases when symptoms become more noticeable, contributing to easing the overall symptom load. It is applied in scenarios where additional management of discomfort is required to assist with maintaining functional stability.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Apraxin (Naproxen Sodium), an NSAID, is subject to strict eligibility rules defined by government regulatory agencies to minimize risk in vulnerable populations.

Populations Contraindicated (Must Not Use) Age & Physiological Restrictions
Known hypersensitivity to Naproxen or any other NSAID (e.g., aspirin) Use is contraindicated in the third trimester of pregnancy (from 30 weeks) and not recommended during lactation.
History of NSAID-induced asthma or allergic reactions Use is mathbfrestricted between 20 and 30 weeks of pregnancy (lowest dose/shortest duration).
Active GI bleeding or peptic ulceration (or history of recurrent disease) Safety and efficacy are not established in children mathbfunder 5 years of age.
Severe mathbfheart, renal (e.g., CrCl < 30 mL/min), or mathbfhepatic mathbffailure Geriatric patients must use the mathbflowest effective dose due to increased risk of serious adverse events.
Post-mathbfCoronary Artery Bypass Graft (CABG) surgery Use is not recommended in women mathbfattempting to conceive (due to potential reversible impact on fertility).

Apraxin is officially allowed for adults and is specifically approved for children mathbfge 5 years for the management of Juvenile Idiopathic Arthritis ( JIA). For all populations with compromised renal or hepatic function that is not classified as severe, use requires special caution and mathbfmonitoring.

What should I know about interactions with other medicines?

Apraxin (Naproxen) is a Nonsteroidal Anti-Inflammatory Drug (NSAID) with several clinically significant interactions. It should not be used concomitantly with other naproxen-containing products or other NSAIDs like ibuprofen, as this substantially increases the risk of serious gastrointestinal side effects, including bleeding, ulceration, and perforation. Use with analgesic doses of Aspirin is generally not recommended.

Interacting Medicines and Classes

Product Category Interaction Mechanism and Effect
Anticoagulants (e.g., Warfarin) & Anti-platelet Agents (e.g., Aspirin, SSRIs) Significantly increases the risk of bleeding.
ACE Inhibitors, ARBs, & Diuretics (e.g., Furosemide) May diminish the antihypertensive and diuretic effects, potentially causing a worsening of kidney function, especially in the elderly or volume-depleted patients.
Lithium & Methotrexate Naproxen can decrease the clearance of these drugs, leading to elevated and potentially toxic serum concentrations. Monitoring of drug levels is necessary.
Digoxin Can increase the serum concentration and prolong the half-life of Digoxin.
Corticosteroids Increases the risk of serious gastrointestinal bleeding and ulceration.

Additionally, concomitant use with Antacids or Sucralfate may decrease the absorption of naproxen. Patients using Probenecid may experience elevated naproxen plasma levels, which could require a dose adjustment. Alcohol and tobacco use also compound the risk of gastrointestinal bleeding.

Mechanism of Action

How Apraxin Works

Apraxin's mechanism is defined by its ability to interfere with specific signaling pathways at the molecular level, thereby influencing key metabolic cascades. The drug acts as a non-selective, reversible inhibitor of the Cyclooxygenase (COX) enzyme system, targeting both the constitutive isoform (COX-1) and the inducible isoform (COX-2). This interaction is the core mechanistic focus.

The molecule competitively occupies the enzyme's active site, halting the initial step in the Prostaglandin Synthesis Pathway and preventing the conversion of arachidonic acid into various prostanoid mediators. This primary action initiates a molecular cascade that leads to the reduction of signaling within affected physiological pathways.

Simultaneously, the drug acts centrally by inhibiting prostaglandin synthesis in the hypothalamus, which alters the prostaglandin-dependent input to the thermal regulation center. Peripherally, the reduction in chemical mediators influences vascular tone and nerve excitability. The drug is formulated as a sodium salt, which accelerates the rate at which the active molecule enters systemic circulation, increasing the speed of target molecule delivery for earlier engagement of the COX inhibition mechanism.

Dosage and Administration Information

Administration Guidelines

Apraxin, based on Naproxen Sodium, is intended for oral administration only. The fundamental principle governing its use is to employ the lowest effective dosage for the shortest possible duration consistent with individual treatment requirements.

Dosing Patterns and Frequency

Dosing is differentiated for chronic versus acute management. For chronic conditions such as osteoarthritis, the common maintenance range is typically 275 mg to 550 mg of naproxen sodium (or equivalent naproxen base) administered twice daily. For acute pain management, the initial dose is generally 550 mg naproxen sodium, followed by doses of 275 mg every 6 to 8 hours or 550 mg every 12 hours, as needed. The total daily dose for acute use should not exceed 1375 mg on the first day, and subsequent days must not exceed 1100 mg.

Administration Instructions

To help minimize gastrointestinal upset, Apraxin is typically taken with or immediately after food or milk, accompanied by a full glass of water. It is important that delayed-release and extended-release tablets be swallowed whole; they must not be crushed, broken, or chewed, as this compromises the intended drug release characteristics.

Population-Specific Use

Usage guidelines include specific adjustments for certain populations. A lower dose should be considered for older adults. Furthermore, the use of this medicine is generally not recommended for individuals with moderate to severe renal impairment, specifically when creatinine clearance is less than 30 mL/min. For children with Juvenile Idiopathic Arthritis, the dosing is weight-based, typically 10 mg/kg/day of naproxen, divided into two doses.

Recent Clinical Evidence

Research evidence / Overview of studies for Apraxin

Research involving Naproxen Sodium (Apraxin) focuses on evaluating various measurements of symptoms, including physical discomfort and functional capacity, across different conditions. Evidence is derived primarily from randomized controlled trials (RCTs) and systematic reviews, which describe how symptoms are measured in a research setting.


Evidence for Acute Pain Management and Symptomatic Relief

Research has explored Naproxen Sodium in conditions characterized by acute or disruptive episodes, such as headaches, muscle pain, and menstrual pain. Researchers primarily used short-term, randomized controlled trials applied in studies examining patient-reported experiences. These studies monitored specific metrics, including pain intensity difference scores and the duration until rescue medication was needed, among trial participants.

Research reports data collected on symptom measurements during short timeframes, but the design of most trials focused on a single episode or very short-term use (often only a few hours to a few days). This means the research does not fully characterize symptom patterns beyond this timeframe.

Evidence for Use in Inflammatory Conditions

Naproxen Sodium was observed in studies focused on chronic conditions, with research examining metrics related to functional limitations and inflammatory states, such as Osteoarthritis (OA) and Rheumatoid Arthritis (RA). The study outcomes examined focused on symptomatic changes, including pain scores and measures reflecting daily functioning or activity level.

Studies reported patterns observed in the data, including metrics related to functional capacity and subjective pain scores, among participants with chronic conditions. However, the research design is primarily aimed at measuring symptomatic outcomes; studies are not designed to evaluate changes in the underlying progression of the inflammatory joint disease or joint damage.

Key Areas Where Research Remains Uncertain

Research highlights what is known—and what is still uncertain. Long-term effects are not fully established by controlled clinical trials designed specifically for durability testing over many years. Data for certain groups remain insufficient to draw specific conclusions about differences in response across varying disease severity or comorbidity-defined groups. Follow-up durations were limited in many acute studies, restricting conclusions to immediate, short-term changes.

Key Studies & References

  1. Naproxen - StatPearls (Source of approved indications and disease course information)

Frequently Asked Questions (FAQ)

Common questions about Apraxin (FAQ)

Q: How quickly does Apraxin start working for joint pain?

A: Studies on Naproxen Sodium (the active ingredient in Apraxin) indicate that the medication is designed for rapid absorption into the bloodstream. Peak concentration in the body is generally reached within one to two hours after taking a dose. Some clinical data, as reflected in the product information, suggest that the onset of pain relief may be observed within approximately 30 minutes of administration.


Q: Can Apraxin cause drowsiness or make you tired?

A: Yes, official drug labels list drowsiness as a possible adverse reaction that may affect the nervous system. Regulatory documents mention that due to the potential for drowsiness, patients who experience this effect should use caution when engaging in activities that require full mental alertness.


Q: What should I do if I experience a severe allergic reaction to Apraxin?

A: The drug label includes warnings about the potential for severe, sometimes fatal, allergic reactions, such as anaphylaxis. Regulatory warnings indicate that if symptoms consistent with a severe allergic reaction are observed, immediate emergency medical attention is necessary.


Q: Can taking Apraxin affect my liver enzymes?

A: NSAIDs like Apraxin have been associated with a condition called hepatotoxicity, which means the potential for liver damage. Regulatory information notes that due to this association, monitoring of liver function may be necessary as part of clinical care.


Q: What symptoms indicate I should stop taking Apraxin and call a doctor?

A: Official warnings strongly emphasize that if symptoms related to serious adverse events are experienced, the medication should be stopped and medical attention sought immediately. These include signs of cardiovascular problems (like chest pain, shortness of breath, or sudden weakness) or severe gastrointestinal issues (such as black/tarry stools, vomiting blood, or unusual stomach pain).


Q: Can Apraxin be used for headaches or migraines?

A: Apraxin is officially indicated for the management of mild to moderate pain. Studies cited in regulatory documents confirm its use for specific types of pain like primary dysmenorrhea (menstrual cramps). Some naproxen formulations are also specifically authorized for the treatment of migraines.


Q: How long does the effect of one dose of Apraxin typically last?

A: Official information indicates that Naproxen has a relatively long elimination half-life, meaning it stays in the body for an extended time, ranging from 12 to 17 hours. Clinical data indicate that the intended pain-relieving effect of a single dose may last up to 12 hours.


Q: Is it normal to have mild stomach upset when first starting Apraxin?

A: Yes, dyspepsia (indigestion or stomach upset) and abdominal pain are officially listed among the most commonly reported adverse reactions for Naproxen Sodium. While the medication is typically taken with food to reduce this risk, experiencing mild stomach upset is a frequent occurrence.


Q: Are there generic versions of Apraxin available?

A: Yes, the regulatory databases, such as the FDA’s DailyMed, include documentation for generic versions of Naproxen Sodium tablets. These generic drugs have been authorized through an established regulatory process.


Q: Is Apraxin recommended for post-operative pain relief?

A: Official indications show Apraxin is authorized for the relief of mild to moderate pain. Clinical trials referenced in regulatory documents have specifically evaluated its effectiveness for various types of post-surgical pain, including orthopedic and postpartum pain.


Q: Does Apraxin have a risk of dependence or addiction?

A: No. The active ingredient, Naproxen Sodium, is not classified as a controlled substance. The official regulatory label for the drug product explicitly indicates that there is no known risk of dependence or addiction associated with its use.


Q: Why is Apraxin sometimes preferred for chronic conditions?

A: Official pharmacokinetic data indicates that the drug has a relatively long elimination half-life of 12 to 17 hours. This chemical property, which is tied to the long half-life, is considered beneficial for the sustained management of chronic inflammatory conditions.


Q: Is it true that Apraxin should be taken with food?

A: Yes, regulatory instructions recommend that Apraxin is typically taken with or immediately after food, or with milk, along with a full glass of water. This is advised to help minimize the risk of gastrointestinal upset, which is a known side effect.


Q: Can young adults take Apraxin for sports injuries?

A: Apraxin is indicated for the treatment of pain associated with inflammatory conditions like tendinitis and bursitis, which are common sports injuries. Usage for young adults and older teenagers is typically guided by adult dosage considerations as determined by a healthcare provider.


Q: What is the difference between Apraxin and other Cox-2 inhibitors?

A: The official mechanism of action states that Apraxin (Naproxen) is a non-selective inhibitor of the Cyclooxygenase (COX) enzyme system, meaning it blocks both the COX-1 and COX-2 enzymes. A selective COX-2 inhibitor, by contrast, is designed to target only the COX-2 enzyme.


Q: Is Apraxin available in different strengths?

A: Yes, according to official dosage form information, Naproxen Sodium is manufactured and available in multiple dosage forms. For example, immediate-release tablets are commonly offered in varying strengths.


Q: What does the latest research say about the long-term safety of Apraxin?

A: Regulatory documents include a serious warning that the risk of major adverse events, particularly cardiovascular or gastrointestinal issues, is not limited to long-term use. This risk may occur early in treatment and generally increases with the duration of use.


Q: Are there any known interactions with birth control pills and Apraxin?

A: While major regulatory interaction lists do not typically highlight a specific interaction between Naproxen and oral contraceptives, regulatory guidance emphasizes that patients should inform their healthcare provider of all concurrent medications, including any form of birth control.


Q: What are the potential signs of an overdose of Apraxin?

A: Official information indicates that symptoms of an overdose of Naproxen Sodium may include central nervous system effects such as drowsiness, severe headache, dizziness, and ringing in the ears. Gastrointestinal issues like stomach pain and heartburn are also possible, and severe overdoses can lead to serious complications.


Q: Is Apraxin safe for teenagers?

A: Safety and efficacy are officially established for children aged five years and older for the treatment of Juvenile Idiopathic Arthritis. For older teenagers, dosage considerations are typically guided by adult use, as determined by a healthcare provider.


Q: Is Apraxin a prescription-only medication?

A: The active ingredient, Naproxen, is available in both over-the-counter (OTC) and prescription-only strengths. Generally, lower strengths are available OTC, and higher strengths require a prescription.

How should Apraxin be stored and disposed of?

How to Store and Dispose of Apraxin?

Official regulatory documentation requires specific conditions to preserve the stability of Apraxin (Naproxen Sodium). The product must be stored at controlled room temperature, generally between 20°C and 25°C. It must be protected from moisture, and the oral suspension formulation must not be frozen. All forms must be kept in the original container, tightly closed.

Storage Requirement Official Condition
Temperature Controlled Room Temperature
Protection Protect from Moisture; Do Not Freeze (Suspension)
Container Keep Tightly Closed in Original Container
Child Safety Keep Out of Sight and Reach of Children

Any unused or expired medication must be handled according to official disposal guidelines. This involves utilizing a drug take-back program if available or mixing the product with an undesirable substance for disposal in household trash, ensuring it is not flushed down the toilet.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Apraxin found in:

A-Z Index: